Breast adenocarcinoma recurring as small cell carcinoma in a patient with a germline BRCA2 mutation: clonal evolution unchecked

بواسطة Niravath, Polly, Eble, Tanya, Contreras, Alejandro, Li, Marilyn, Franco, Luis M, Rimawi, Mothaffar
الحاوية / القاعدة Exp Hematol Oncol (2015)

Towards personalized treatment for early stage HER2-positive breast cancer

بواسطة Goutsouliak, Kristina, Veeraraghavan, Jamunarani, Sethunath, Vidyalakshmi, De Angelis, Carmine, Osborne, C. Kent, Rimawi, Mothaffar F., Schiff, Rachel
الحاوية / القاعدة Nat Rev Clin Oncol (2019)

A Phase II Trial of Capecitabine Concomitantly With Whole-Brain Radiotherapy Followed by Capecitabine and Sunitinib for Brain Metastases From Breast Cancer

بواسطة Niravath, Polly, Tham, Yee Lu, Wang, Tao, Rodriguez, Angel, Foreman, Claudette, Hilsenbeck, Susan G., Elledge, Richard, Rimawi, Mothaffar
الحاوية / القاعدة Oncologist (2015)

EGFR Expression in Breast Cancer Association with biologic phenotype and clinical outcomes

بواسطة Rimawi, Mothaffar F., Shetty, Priya B., Weiss, Heidi L., Schiff, Rachel, Osborne, C. Kent, Chamness, Gary C., Elledge, Richard M.
منشور في 2010

De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance

بواسطة Veeraraghavan, Jamunarani, De Angelis, Carmine, Reis-Filho, Jorge S., Prat, Aleix, Rimawi, Mothaffar F., Pascual, Tomás, Osborne, C. Kent, Schiff, Rachel
الحاوية / القاعدة Breast (2017)

THERAPEUTIC POTENTIAL OF THE DUAL EGFR/HER2 INHIBITOR AZD8931 IN CIRCUMVENTING ENDOCRINE RESISTANCE

بواسطة Morrison, Gladys, Fu, Xiaoyong, Shea, Marty, Nanda, Sarmistha, Giuliano, Mario, Wang, Tao, Klinowska, Teresa, Osborne, C. Kent, Rimawi, Mothaffar F., Schiff, Rachel
منشور في 2014

Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody–drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implication...

بواسطة Lu, Dan, Girish, Sandhya, Gao, Yuying, Wang, Bei, Yi, Joo-Hee, Guardino, Ellie, Samant, Meghna, Cobleigh, Melody, Rimawi, Mothaffar, Conte, Pierfranco, Jin, Jin Yan
منشور في 2014

Lumpectomy followed by radiation improves survival in HER2 positive and triple‐negative breast cancer with high tumor‐infiltrating lymphocytes compared to mastectomy alone

بواسطة Mouabbi, Jason A., Chand, Momal, Asghar, Ishaq A., Sakhi, Ramen, Ockner, Daniel, Dul, Carrie L., Hadid, Tarik, Aref, Amr, Rimawi, Mothaffar F., Hoyos, Valentina
الحاوية / القاعدة Cancer Med (2021)

β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib

بواسطة Huang, Catherine, Park, Catherine C, Hilsenbeck, Susan G, Ward, Robin, Rimawi, Mothaffar F, Wang, Yen-chao, Shou, Jiang, Bissell, Mina J, Osborne, C Kent, Schiff, Rachel
منشور في 2011

A phase II neoadjuvant trial of anastrozole, fulvestrant and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer

بواسطة Massarweh, Suleiman, Tham, Yee L, Huang, Jian, Sexton, Krystal, Weiss, Heidi, Tsimelzon, Anna, Bayer, Amanda, Rimawi, Mothaffar, Cai, Wei Yen, Hilsenbeck, Susan, Fuqua, Suzanne, Elledge, Richard
الحاوية / القاعدة Breast Cancer Res Treat (2011)

Upregulation of Mucin4 in ER-positive/HER2-Overexpressing Breast Cancer Xenografts with Acquired Resistance to Endocrine and HER2-Targeted Therapies

بواسطة Chen, Albert C., Migliaccio, Ilenia, Rimawi, Mothaffar, Lopez-Tarruella, Sara, Creighton, Chad J., Massarweh, Suleiman, Huang, Catherine, Wang, Yen-Chao, Batra, Surinder K., Gutierrez, M. Carolina, Osborne, C. Kent, Schiff, Rachel
منشور في 2012

Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER-2/neu Overexpressing Breast Tumor Xenografts

بواسطة Rimawi, Mothaffar F., Wiechmann, Lisa S., Wang, Yen-Chao, Huang, Catherine, Migliaccio, Ilenia, Wu, Meng-Fen, Gutierrez, Carolina, Hilsenbeck, Susan G., Arpino, Grazia, Massarweh, Suleiman, Ward, Robin, Soliz, Robert, Osborne, C. Kent, Schiff, Rachel
منشور في 2010

High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy

بواسطة Litzenburger, Beate C., Creighton, Chad J., Tsimelzon, Anna, Chan, Bonita T., Hilsenbeck, Susan G., Wang, Tao, Carboni, Joan M., Gottardis, Marco M., Huang, Fei, Chang, Jenny C., Lewis, Michael T., Rimawi, Mothaffar F., Lee, Adrian V.
منشور في 2010

Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexp...

بواسطة Rimawi, Mothaffar F., Mayer, Ingrid A., Forero, Andres, Nanda, Rita, Goetz, Matthew P., Rodriguez, Angel A., Pavlick, Anne C., Wang, Tao, Hilsenbeck, Susan G., Gutierrez, Carolina, Schiff, Rachel, Osborne, C. Kent, Chang, Jenny C.
منشور في 2013

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Lo...

بواسطة Dave, Bhuvanesh, Migliaccio, Ilenia, Gutierrez, M. Carolina, Wu, Meng-Fen, Chamness, Gary C., Wong, Helen, Narasanna, Archana, Chakrabarty, Anindita, Hilsenbeck, Susan G., Huang, Jian, Rimawi, Mothaffar, Schiff, Rachel, Arteaga, Carlos, Osborne, C. Kent, Chang, Jenny C.
منشور في 2011

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers -- role of estrogen receptor and HER2 reactivation

بواسطة Wang, Yen-Chao, Morrison, Gladys, Gillihan, Ryan, Guo, Jun, Ward, Robin M, Fu, Xiaoyong, Botero, Maria F, Healy, Nuala A, Hilsenbeck, Susan G, Phillips, Gail Lewis, Chamness, Gary C, Rimawi, Mothaffar F, Osborne, C Kent, Schiff, Rachel
منشور في 2011

Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and an...

بواسطة Ramirez, Arturo B., Bhat, Raksha, Sahay, Debashish, De Angelis, Carmine, Thangavel, Hariprasad, Hedayatpour, Sina, Dobrolecki, Lacey E., Nardone, Agostina, Giuliano, Mario, Nagi, Chandandeep, Rimawi, Mothaffar, Osborne, C. Kent, Lewis, Michael T., Stilwell, Jackie L., Kaldjian, Eric P., Schiff, Rachel, Trivedi, Meghana V.
الحاوية / القاعدة BMC Cancer (2019)

Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27

بواسطة Niravath, Polly, Chen, Bingshu, Chapman, Judy-Anne W., Agarwal, Sandeep K., Welschhans, Robert L., Bongartz, Tim, Kalari, Krishna R., Shepherd, Lois E., Bartlett, John, Pritchard, Kathleen, Gelmon, Karen, Hilsenbeck, Susan G., Rimawi, Mothaffar F., Osborne, C. Kent, Goss, Paul E., Ingle, James N.
الحاوية / القاعدة Clin Breast Cancer (2017)

Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor-Negative Breast Cancer

بواسطة Crew, Katherine D., Brown, Powel, Greenlee, Heather, Bevers, Therese B., Arun, Banu, Hudis, Clifford, McArthur, Heather L., Chang, Jenny, Rimawi, Mothaffar, Vornik, Lana, Cornelison, Terri L., Wang, Antai, Hibshoosh, Hanina, Ahmed, Aqeel, Terry, Mary Beth, Santella, Regina M., Lippman, Scott M., Hershman, Dawn L.
منشور في 2012

The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance

بواسطة Nardone, Agostina, Weir, Hazel, Delpuech, Oona, Brown, Henry, De Angelis, Carmine, Cataldo, Maria Letizia, Fu, Xiaoyong, Shea, Martin J., Mitchell, Tamika, Veeraraghavan, Jamunarani, Nagi, Chandandeep, Pilling, Mark, Rimawi, Mothaffar F., Trivedi, Meghana, Hilsenbeck, Susan G., Chamness, Gary C., Jeselsohn, Rinath, Osborne, C. Kent, Schiff, Rachel
الحاوية / القاعدة Br J Cancer (2018)